Published in J Exp Med on September 01, 1975
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Immunopathology of Schistosoma mansoni infection. Clin Microbiol Rev (1989) 1.79
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
Eosinophil-enriched inflammatory response to schistosomula in the skin of mice immune to Schistosoma mansoni. Am J Pathol (1976) 1.19
Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. J Clin Invest (1977) 1.12
Role of host granulomatous response in murine schistosomiasis mansoni. eosinophil-mediated destruction of eggs. J Clin Invest (1980) 0.98
Interleukin 5 (IL-5) is not required for expression of a Th2 response or host resistance mechanisms during murine schistosomiasis mansoni but does play a role in development of IL-4-producing non-T, non-B cells. Infect Immun (1999) 0.93
Cell-mediated immunity and its role in resistance to infection. West J Med (1977) 0.85
Kinetics of interleukin-6 production after experimental infection of mice with Schistosoma mansoni. Immunology (1996) 0.83
The effect of antiserum to eosinophils and susceptibility and acquired immunity of the guinea-pig to trichostronglyus colubriformis. Immunology (1979) 0.82
Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue. Am J Pathol (1988) 0.78
The origin and kinetics of mononuclear phagocytes. J Exp Med (1968) 14.96
Ultrastructure of human leukocytes after simultaneous fixation with glutaraldehyde and osmium tetroxide and "postfixation" in uranyl acetate. J Cell Biol (1968) 11.00
Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50
Mechanism of eosinophilia. II. Role of the lymphocyte. J Exp Med (1970) 4.34
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
Mechanism of eosinophilia. I. Factors affecting the eosinophil response of rats to Trichinella spiralis. J Exp Med (1970) 3.40
Quantitative studies of blood and bone marrow neutrophils in normal mice. Am J Physiol (1968) 3.33
Segregation and packaging of granule enzymes in eosinophilic leukocytes. J Cell Biol (1970) 2.94
A revised method for isolation of Schistosoma mansoni eggs for biological experimentation. Proc Soc Exp Biol Med (1957) 2.80
Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59
Plasma and blood volumes of mouse organs, as determined with radioactive iodoproteins. Proc Soc Exp Biol Med (1950) 2.07
The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03
The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91
Eosinophils and immune mechanisms. Eosinophil stimulation promoter (ESP): a lymphokine induced by specific antigen or phytohemagglutinin. J Immunol (1973) 1.89
Pulmonary ascariasis resembling eosinophilic lung; autopsy report with description of larvae in the bronchioles. Am J Trop Med Hyg (1958) 1.33
Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol (1975) 1.27
Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med (1974) 1.27
Schistosoma mansoni: eosinophilia and the development of lymphocyte blastogenesis in response to soluble egg antigen in inbred mice. Exp Parasitol (1972) 1.17
Schistosoma mansoni infection in mice depleted of thymus-dependent lymphocytes. I. Eosinophilia and immunologic responses to a schistosomal egg preparation. Am J Pathol (1973) 1.14
Production of a rabbit antimouse eosinophil serum with no cross-reactivity to neutrophils. J Exp Med (1973) 1.11
Antineutrophilic serum, its use in studies of white blood cell dynamics. J Lab Clin Med (1967) 1.04
In vivo suppression by cholera toxin of cell-mediated and foreign body inflammatory responses. J Immunol (1974) 1.03
In vivo microscopic observations of the pathogenesis and pathophysiology of hepatosplenic schistosomiasis in the mouse liver. Am J Trop Med Hyg (1972) 0.99
Monospecific antigranulocyte sera against human neutrophils, eosinophils, basophils, and myeloblasts. Lancet (1974) 0.91
Comparison of penetration and maturation of Schistosoma mansoni in the hamster, mouse, guinea pig, rabbit, and rat. Am J Trop Med Hyg (1967) 0.90
Influence of Schistosoma mansoni infections on the eosinophil level of adrenalectomized mice. Exp Parasitol (1953) 0.79
Algorithms in the diagnosis and management of exotic diseases. I. Schistosomiasis. J Infect Dis (1975) 0.78
The early stages of absorption of injected horseradish peroxidase in the proximal tubules of mouse kidney: ultrastructural cytochemistry by a new technique. J Histochem Cytochem (1966) 46.81
Selective primary health care: an interim strategy for disease control in developing countries. N Engl J Med (1979) 10.02
Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from Schistosoma mansoni eggs. J Exp Med (1970) 4.50
Giardiasis in the mouse: an animal model. Gastroenterology (1976) 4.47
Glomerular permeability. Ultrastructural cytochemical studies using peroxidases as protein tracers. J Exp Med (1966) 4.09
Granuloma formation around schistosome eggs as a manifestation of delayed hypersensitivity. Am J Pathol (1967) 4.04
Mutations affecting the formation and function of the cardiovascular system in the zebrafish embryo. Development (1996) 3.63
Metabolic and morphological observations on the effect of surface-active agents of leukocytes. J Cell Biol (1967) 3.53
A chromosome bin map of 16,000 expressed sequence tag loci and distribution of genes among the three genomes of polyploid wheat. Genetics (2004) 3.37
Eosinophils as mediators of antibody-dependent damage to schistosomula. Nature (1975) 2.92
Spontaneous modulation of granulomatous hypersensitivity in schistosomiasis mansoni. J Immunol (1975) 2.59
The inhibition of granuloma formation around Schistosoma mansoni eggs. II. Thymectomy. Am J Pathol (1967) 2.23
A role for the eosinophil in acquired resistance to Schistosoma mansoni infection as determined by antieosinophil serum. J Exp Med (1975) 2.19
Endogenous desensitization: changing host granulomatou response to schistosome eggs at different stages of infection with schistosoma mansoni. Am J Pathol (1968) 2.18
Spectrum and possible mechanism of carrageenan cytotoxicity. Am J Pathol (1971) 2.17
Antibody-dependent eosinophil-mediated damage to 51Cr-labeled schistosomula of Schistosoma mansoni: damage by purieid eosinophils. J Exp Med (1977) 2.06
The pathogenesis of "clay-pipe stem cirrhosis" in mice with chronic schistosomiasis mansoni, with a note on the longevity of the schistosomes. Am J Pathol (1966) 2.03
The immunopathogenesis of schistosomiasis: a multidisciplinary approach. Trans R Soc Trop Med Hyg (1972) 1.91
Left-right pattern of cardiac BMP4 may drive asymmetry of the heart in zebrafish. Development (1997) 1.84
Dispersion of papers among journals based on a mathematical analysis of two diverse medical literatures. Nature (1969) 1.79
Lassa fever in Britain: an imported case. Br Med J (1973) 1.72
Acquired resistance to infection in an animal model of giardiasis. J Immunol (1976) 1.70
Eosinophils and resistance to Trichinella spiralis. J Exp Med (1977) 1.68
Tropical medicine. BMJ (2000) 1.67
Schistosomiasis mansoni in Yemeni in California: duration of infection, presence of disease, therapeutic management. Am J Trop Med Hyg (1974) 1.61
The inhibition of granuloma formation around Schistosoma mansoni eggs. 3. Heterologous antilymphocyte serum. Am J Pathol (1968) 1.58
Granuloma formation around Schistosoma mansoni, S. HAEMATOBIUM, AND S. japonicum eggs. Size and rate of development, cellular composition, cross-sensitivity, and rate of egg destruction. Am J Trop Med Hyg (1970) 1.56
Regulation of the prevalence and intensity of schistosomiasis in man: immunology or ecology? J Infect Dis (1973) 1.47
The role of chemical mediators in the inflammatory response induced by foreign bodies: comparison with the schistosome egg granuloma. J Exp Med (1970) 1.44
A functional classification of granulomatous inflammation. Ann N Y Acad Sci (1976) 1.44
An application of the Kermack-McKendrick theory to the epidemiology of schistosomiasis. Am J Trop Med Hyg (1970) 1.43
Quick Kato smear for field quantification of Schistosoma mansoni eggs. Am J Trop Med Hyg (1980) 1.43
How to obtain emergency drugs. Can Med Assoc J (1981) 1.42
Thymus dependency of host resistance to Giardia muris infection: studies in nude mice. J Immunol (1978) 1.42
Suppressive effect of a chronic helminth infection, schistosomiasis mansoni, on the in vitro responses of spleen and lymph node cells to the T cell mitogens phytohemagglutinin and concanavalin A. Infect Immun (1976) 1.42
Induced and spontaneous diabetes mellitus and suppression of cell-mediated immunologic responses. Granuloma formation, delayed dermal reactivity and allograft rejection. J Clin Invest (1976) 1.41
Kinins--possible physiologic and pathologic roles in man. N Engl J Med (1968) 1.41
Long-term management after splenectomy. ... has been amended. BMJ (1994) 1.39
Suppression of cell-mediated immunity by metronidazole. Int Arch Allergy Appl Immunol (1977) 1.37
Peroxidase-mediated toxicity to schistosomula of Schistosoma mansoni. J Immunol (1981) 1.35
Hepatosplenic schistosomiasis mansoni: an immunologic disease. Bull N Y Acad Med (1975) 1.34
The histochemical demonstration of uricase activity. J Histochem Cytochem (1966) 1.34
Analysis of expressed sequence tag loci on wheat chromosome group 4. Genetics (2004) 1.33
The inhibition of granuloma formation around Schistosoma mansoni eggs. I. Immunosuppressive drugs. Am J Trop Med Hyg (1967) 1.33
Th ecology of the medical literatures. Am J Med Sci (1972) 1.32
Tropomyosin isoforms in nonmuscle cells. Int Rev Cytol (1997) 1.31
Dynamics of antigen and mitogen-induced responses in murine schistosomiasis japonica: in vitro comparison between hepatic granulomas and splenic cells. J Immunol (1981) 1.31
Selective primary health care: an interim strategy for disease control in developing countries. Soc Sci Med Med Econ (1980) 1.31
Defective "pacemaker" current (Ih) in a zebrafish mutant with a slow heart rate. Proc Natl Acad Sci U S A (1997) 1.30
Chromosome bin map of expressed sequence tags in homoeologous group 1 of hexaploid wheat and homoeology with rice and Arabidopsis. Genetics (2004) 1.29
Anti-inflammatory effects of tartar emetic and niridazole: suppression of schistosome egg granuloma. J Immunol (1974) 1.29
The Schistosoma mansoni egg granuloma: quantitation of cell populations. J Pathol (1977) 1.29
The secretion of migration inhibitory factor by intact schistosome egg granulomas maintained in vitro. Nature (1973) 1.28
Niridazole. II. A potent long-acting suppressant of cellular hypersensitivity. J Immunol (1975) 1.27
Production of monospecific rabbit antihuman eosinophil serums and demonstration of a blocking phenomenon. N Engl J Med (1974) 1.27
Impairment of cell-mediated immunity in mutation diabetic mice (db/db). J Immunol (1978) 1.26
Algorithms in the diagnosis and management of exotic diseases. XXIV. Leishmaniases. J Infect Dis (1977) 1.25
Bovine lactoperoxidase as a cytochemical protein tracer for electron microscopy. J Histochem Cytochem (1968) 1.25
Drugs five years later: praziquantel. Ann Intern Med (1989) 1.23
Increased incidence of hepatoma in mice with chronic schistosomiasis mansoni treated with a carcinogen. Am J Pathol (1967) 1.23
Role of cell-generated hydrogen peroxide in granulocyte-mediated killing of schistosomula of Schistosoma mansoni in vitro. J Clin Invest (1981) 1.22
Peroxidase arthritis. II. Lymphoid cell-endothelial interactions during a developing immunologic inflammatory response. Am J Pathol (1972) 1.22
Calcium extrusion is critical for cardiac morphogenesis and rhythm in embryonic zebrafish hearts. Proc Natl Acad Sci U S A (2005) 1.21
Schistosoma mansoni soluble egg antigens. I. Identification and purification of three major antigens, and the employment of radioimmunoassay for their further characterization. J Immunol (1976) 1.21
Algorithms in the Diagnosis and Management of Exotic Diseases. ii. Giardiasis. J Infect Dis (1975) 1.21
In vitro killing of schistosomula of Schistosoma mansoni by BCG and C. parvum-activated macrophages. J Immunol (1979) 1.21
Adoptive transfer of modulation of granuloma formation and hepatosplenic disease in murine schistosomiasis japonica by serum from chronically infected animals. J Immunol (1982) 1.20
Morbidity in Schistosomiasis mansoni in relation to intensity of infection: study of a community in Machakos, Kenya. Am J Trop Med Hyg (1976) 1.19
Urinary tract morbidity in schistosomiasis haematobia: associations with age and intensity of infection in an endemic area of Coast Province, Kenya. Am J Trop Med Hyg (1988) 1.19
Field studies of a rapid, accurate means of quantifying Schistosoma haematobium eggs in urine samples. Bull World Health Organ (1976) 1.19
Suppression of delayed hypersensitivity in schistosome-infected patients by niridazole. N Engl J Med (1975) 1.18
Rapid, accurate quantification of schistosome eggs via nuclepore filters. J Parasitol (1976) 1.18
Chemotherapy-based control of schistosomiasis haematobia. 3. Snail studies monitoring the effect of chemotherapy on transmission in the Msambweni area, Kenya. Trans R Soc Trop Med Hyg (1990) 1.17
Acquired resistance to infection with Schistosoma mansoni induced by Toxoplasma gondii. Nature (1976) 1.16
The Schistosoma japonicum egg granuloma. II. Cellular composition, granuloma size, and immunologic concomitants. Am J Trop Med Hyg (1978) 1.16
Genetic differences in BCG-induced resistance to Schistosoma mansoni are not controlled by genes within the major histocompatibility complex of the mouse. J Immunol (1978) 1.14
Eosinophilopoietin. A circulating low molecular weight peptide-like substance which stimulates the production of eosinophils in mice. J Clin Invest (1977) 1.12
Role of arginase in killing of schistosomula of Schistosoma mansoni. J Exp Med (1980) 1.12
Predisposition to urinary tract epithelial metaplasia in Schistosoma haematobium infection. Am J Trop Med Hyg (2001) 1.12
Production of a rabbit antimouse eosinophil serum with no cross-reactivity to neutrophils. J Exp Med (1973) 1.11
Schistosomiasis haematobia in coast province Kenya. Relationship between egg output and morbidity. Am J Trop Med Hyg (1979) 1.11